Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 625.00 | 303.79 | 658.00 | 729.75 | 0.9017 | 0.8428 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 625.00 | 303.79 | 732.00 | 729.75 | 1.0031 | 1.0049 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 625.00 | 303.79 | 760.00 | 729.75 | 1.0415 | 1.0653 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 684.00 | 729.75 | 0.9373 | 0.9002 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 578.00 | 729.75 | 0.7921 | 0.6632 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 454.00 | 729.75 | 0.6221 | 0.3741 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 599.00 | 729.75 | 0.8208 | 0.7108 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 625.00 | 303.79 | 677.00 | 729.75 | 0.9277 | 0.8848 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 625.00 | 303.79 | 377.00 | 729.75 | 0.5166 | 0.1862 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 625.00 | 303.79 | 640.00 | 729.75 | 0.8770 | 0.8028 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 625.00 | 303.79 | 830.00 | 729.75 | 1.1374 | 1.2144 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 625.00 | 303.79 | 686.00 | 729.75 | 0.9401 | 0.9046 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 625.00 | 303.79 | 380.00 | 729.75 | 0.5207 | 0.1937 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 625.00 | 303.79 | 770.00 | 729.75 | 1.0552 | 1.0868 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 625.00 | 303.79 | 806.00 | 729.75 | 1.1045 | 1.1636 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 625.00 | 303.79 | 924.00 | 729.75 | 1.2662 | 1.4105 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 625.00 | 303.79 | 682.00 | 729.75 | 0.9346 | 0.8958 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 625.00 | 303.79 | 792.00 | 729.75 | 1.0853 | 1.1338 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 625.00 | 303.79 | 815.00 | 729.75 | 1.1168 | 1.1826 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 625.00 | 303.79 | 829.00 | 729.75 | 1.1360 | 1.2122 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 625.00 | 303.79 | 894.00 | 729.75 | 1.2251 | 1.3483 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 914.00 | 729.75 | 1.2525 | 1.3898 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 625.00 | 303.79 | 386.00 | 729.75 | 0.5290 | 0.2086 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 625.00 | 303.79 | 815.00 | 729.75 | 1.1168 | 1.1826 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 625.00 | 303.79 | 718.00 | 729.75 | 0.9839 | 0.9745 |